IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS.

Clinical trial NCT06166030 · UNKNOWN

Trial details

NCT number: NCT06166030
Sponsor: Federal University of São Paulo
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Long Covid19 Dietary Supplements Respiratory Tract Infections Inflammation

Start date: 2023-12-10
Primary completion: 2024-12-10
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.